SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-16-011964
Filing Date
2016-08-26
Accepted
2016-08-26 17:17:14
Documents
7
Period of Report
2016-08-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_082616.htm 8-K 15989
2 EXHIBIT 10.1 exh_101.htm EX-10.1 151192
3 EXHIBIT 10.2 exh_102.htm EX-10.2 60941
4 EXHIBIT 10.3 exh_103.htm EX-10.3 124082
5 EXHIBIT 10.4 exh_104.htm EX-10.4 92538
6 EXHIBIT 10.5 exh_105.htm EX-10.5 183713
7 EXHIBIT 99.1 exh_991.htm EX-99.1 7198
  Complete submission text file 0001171843-16-011964.txt   636889
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21214 | Film No.: 161855534
SIC: 2834 Pharmaceutical Preparations